Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Prognostic Factors and Long-Term Outcome Prediction in Patients with Hypopharyngeal Carcinoma Treated with (Chemo)radiotherapy: Development of a Prognostic Model

M. Pala, P. Novakova, A. Tesar, L. Vesela, A. Vrana, J. Sukova, Z. Pechacova, P. Holeckova, T. Drbohlavova, T. Podlesak, P. Tesarova

. 2025 ; 13 (2) : . [pub] 20250209

Status neindexováno Jazyk angličtina Země Švýcarsko

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc25008447

Background/Objectives: To evaluate the effectiveness of curative (chemo)radiotherapy in patients with hypopharyngeal carcinoma and to identify prognostic factors influencing treatment outcomes. Methods: We conducted a retrospective study of 173 consecutive patients, treated with definitive or postoperative (chemo)radiotherapy from 2002 to 2020 [median age 60 years; current/former smokers 95%; UICC stage III/IV 96%]. Radiation therapy was preceded by a radical resection of a primary tumor in 32% of patients. One hundred patients received chemotherapy. Results: The median total dose of radiotherapy achieved was 70 Gy. The five- and ten-year locoregional controls were 63%, and the five- and ten-year distant controls were 77% and 76%, respectively. The five- and ten-year overall survival rates were 24% and 9%, respectively. Conclusions: The results demonstrate the limited effectiveness of curative (chemo)radiotherapy in patients with hypopharyngeal carcinoma with long-term locoregional and distant control of half of the treated patients. The multivariate analysis indicated that initial surgery, chemotherapy, comorbidity score (as assessed by ACE-27), pretreatment tracheostomy, hemoglobin level and initial response to treatment were the strongest prognostic factors in predicting survival. Using these factors, corresponding predictive models were constructed.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc25008447
003      
CZ-PrNML
005      
20250422095742.0
007      
ta
008      
250408s2025 sz f 000 0|eng||
009      
AR
024    7_
$a 10.3390/biomedicines13020417 $2 doi
035    __
$a (PubMed)40002830
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a sz
100    1_
$a Pala, Miloslav $u First Faculty of Medicine, Charles University in Prague, 12108 Prague, Czech Republic $u Institute of Radiation Oncology, Bulovka University Hospital, 18081 Prague, Czech Republic $1 https://orcid.org/0000000284466339 $7 xx0088087
245    10
$a Prognostic Factors and Long-Term Outcome Prediction in Patients with Hypopharyngeal Carcinoma Treated with (Chemo)radiotherapy: Development of a Prognostic Model / $c M. Pala, P. Novakova, A. Tesar, L. Vesela, A. Vrana, J. Sukova, Z. Pechacova, P. Holeckova, T. Drbohlavova, T. Podlesak, P. Tesarova
520    9_
$a Background/Objectives: To evaluate the effectiveness of curative (chemo)radiotherapy in patients with hypopharyngeal carcinoma and to identify prognostic factors influencing treatment outcomes. Methods: We conducted a retrospective study of 173 consecutive patients, treated with definitive or postoperative (chemo)radiotherapy from 2002 to 2020 [median age 60 years; current/former smokers 95%; UICC stage III/IV 96%]. Radiation therapy was preceded by a radical resection of a primary tumor in 32% of patients. One hundred patients received chemotherapy. Results: The median total dose of radiotherapy achieved was 70 Gy. The five- and ten-year locoregional controls were 63%, and the five- and ten-year distant controls were 77% and 76%, respectively. The five- and ten-year overall survival rates were 24% and 9%, respectively. Conclusions: The results demonstrate the limited effectiveness of curative (chemo)radiotherapy in patients with hypopharyngeal carcinoma with long-term locoregional and distant control of half of the treated patients. The multivariate analysis indicated that initial surgery, chemotherapy, comorbidity score (as assessed by ACE-27), pretreatment tracheostomy, hemoglobin level and initial response to treatment were the strongest prognostic factors in predicting survival. Using these factors, corresponding predictive models were constructed.
590    __
$a NEINDEXOVÁNO
655    _2
$a časopisecké články $7 D016428
700    1_
$a Novakova, Pavla $u Radiophysics Department, Bulovka University Hospital, 18001 Prague, Czech Republic
700    1_
$a Tesar, Adam $u First Faculty of Medicine, Charles University in Prague, 12108 Prague, Czech Republic
700    1_
$a Vesela, Lucie $u Institute of Radiation Oncology, Bulovka University Hospital, 18081 Prague, Czech Republic
700    1_
$a Vrana, Antonin $u Institute of Radiation Oncology, Bulovka University Hospital, 18081 Prague, Czech Republic
700    1_
$a Sukova, Jarmila $u Institute of Radiation Oncology, Bulovka University Hospital, 18081 Prague, Czech Republic
700    1_
$a Pechacova, Zdenka $u Institute of Radiation Oncology, Bulovka University Hospital, 18081 Prague, Czech Republic
700    1_
$a Holeckova, Petra $u First Faculty of Medicine, Charles University in Prague, 12108 Prague, Czech Republic $u Institute of Radiation Oncology, Bulovka University Hospital, 18081 Prague, Czech Republic
700    1_
$a Drbohlavova, Tereza $u Institute of Radiation Oncology, Bulovka University Hospital, 18081 Prague, Czech Republic
700    1_
$a Podlesak, Tomas $u Department of Otorhinolaryngology, Bulovka University Hospital, 18001 Prague, Czech Republic
700    1_
$a Tesarova, Petra $u First Faculty of Medicine, Charles University in Prague, 12108 Prague, Czech Republic $u Institute of Radiation Oncology, Bulovka University Hospital, 18081 Prague, Czech Republic $1 https://orcid.org/0000000336073474 $7 xx0102804
773    0_
$w MED00205373 $t Biomedicines $x 2227-9059 $g Roč. 13, č. 2 (2025)
856    41
$u https://pubmed.ncbi.nlm.nih.gov/40002830 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y - $z 0
990    __
$a 20250408 $b ABA008
991    __
$a 20250422095744 $b ABA008
999    __
$a ok $b bmc $g 2306377 $s 1245522
BAS    __
$a 3
BAS    __
$a PreBMC-PubMed-not-MEDLINE
BMC    __
$a 2025 $b 13 $c 2 $e 20250209 $i 2227-9059 $m Biomedicines $n Biomedicines $x MED00205373
LZP    __
$a Pubmed-20250408

Najít záznam

Citační ukazatele

Možnosti archivace